texas oncology more breakthroughs. more victories

Share:

 
 

Lenvatinib Regimen Setting Pace for Emerging Combos in Kidney Cancer

Publication: OncLive

Dr. Thomas E. Hutson of Texas Oncology−Charles A. Sammons Cancer spoke with OncLive about the efficacy of combination therapy to treat advanced renal cell carcinoma (RCC), specifically a 2-drug regimen approved by the FDA in May 2016.

Read the full story from OncLive.

Related Physicians

Related Cancer Centers